Tschudin, member of the management Committee of the Swiss National Bank: Due to the monetary easing policy, Swiss economic growth is expected to pick up slightly next year. Overseas developments are the main risks facing the Swiss economy.European Commission President: Romania and Bulgaria have become full members of the Schengen area. European Commission President Ursula von der Leyen said on social media that Romania and Bulgaria have become full members of the Schengen area.US Treasury Secretary Yellen: The oil market is well supplied and the price is relatively low. US Treasury Secretary Yellen said that the oil market is well supplied and the price is relatively low. Russia has invested a lot of money in its fleet to avoid the western oil price cap sanctions.
Adobe's US stocks fell about 9% before the market, and the company's annual performance guidance was worse than expected.Japan's Shimane nuclear power plant operating company said that there was no abnormality in the reactor water level gauge of Unit 2, which was previously misjudged. On December 12, local time, China Electric Power Company of Japan conducted an investigation on the report that the reactor water level gauge of Unit 2 of Shimane nuclear power plant was once abnormal, and the results showed that there was no abnormality. The company said that the value displayed by the instrument was normal, but the operator misunderstood the data and misjudged it as abnormal. (CCTV News)Rapdidus will start producing 2-nanometer chips in April next year. Dong Zhelang, president of Rapdidus, an advanced Japanese semiconductor foundry company, said that by the end of March 2025, Rapdidus will complete all the equipment setup required for trial production of 2-nanometer chips, and start the trial production line in April to actually produce 2-nanometer chips.
The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)Adobe's US stocks fell about 9% before the market, and the company's annual performance guidance was worse than expected.Rapdidus will start producing 2-nanometer chips in April next year. Dong Zhelang, president of Rapdidus, an advanced Japanese semiconductor foundry company, said that by the end of March 2025, Rapdidus will complete all the equipment setup required for trial production of 2-nanometer chips, and start the trial production line in April to actually produce 2-nanometer chips.
Strategy guide
Strategy guide
12-13
Strategy guide
12-13